Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
- PMID: 23845716
- DOI: 10.1183/09031936.00197712
Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial
Abstract
Several medical associations recommended lung cancer screening by low-dose computed tomography scanning for high-risk groups. Counselling of the candidates on the potential harms and benefits and their lung cancer risk is a prerequisite for screening. In the NELSON trial, screenings are considered positive for (part) solid lung nodules with a volume >500 mm3 and for (part) solid or nonsolid nodules with a volume-doubling time <400 days. For this study, the performance of the NELSON strategy in three screening rounds was evaluated and risk calculations were made for a follow-up period of 5.5 years. 458 (6%) of the 7582 participants screened had a positive screen result and 200 (2.6%) were diagnosed with lung cancer. The positive screenings had a predictive value of 40.6% and only 1.2% of all scan results were false-positive. In a period of 5.5 years, the risk of screen-detected lung cancer strongly depends on the result of the first scan: 1.0% after a negative baseline result, 5.7% after an indeterminate baseline and 48.3% after a positive baseline. The screening strategy yielded few positive and false-positive scans with a reasonable positive predictive value. The 5.5-year lung cancer risk calculations aid clinicians in counselling candidates for lung cancer screening with low-dose computed tomography.
Similar articles
-
Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.Clin Radiol. 2017 May;72(5):389-400. doi: 10.1016/j.crad.2016.12.021. Epub 2017 Feb 4. Clin Radiol. 2017. PMID: 28168954 Review.
-
Lung cancer screening: Current status and perspective.Diagn Interv Imaging. 2016 Oct;97(10):949-953. doi: 10.1016/j.diii.2016.06.018. Epub 2016 Aug 12. Diagn Interv Imaging. 2016. PMID: 27527243 Review.
-
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283862 Clinical Trial.
-
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1. Lancet Oncol. 2014. PMID: 25282285 Clinical Trial.
-
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1. Lancet Oncol. 2014. PMID: 25282284 Clinical Trial.
Cited by
-
Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021.Diagn Progn Res. 2023 Dec 11;7(1):26. doi: 10.1186/s41512-023-00162-0. Diagn Progn Res. 2023. PMID: 38072977 Free PMC article.
-
Perceptions and feelings of a French sample regarding lung cancer screening.BMC Public Health. 2023 Nov 24;23(1):2333. doi: 10.1186/s12889-023-17110-8. BMC Public Health. 2023. PMID: 38001431 Free PMC article.
-
Influence of CT dose reduction on AI-driven malignancy estimation of incidental pulmonary nodules.Eur Radiol. 2024 May;34(5):3444-3452. doi: 10.1007/s00330-023-10348-1. Epub 2023 Oct 23. Eur Radiol. 2024. PMID: 37870625 Free PMC article.
-
Factors influencing the outcome of volumetry tools for pulmonary nodule analysis: a systematic review and attempted meta-analysis.Insights Imaging. 2023 Sep 23;14(1):152. doi: 10.1186/s13244-023-01480-z. Insights Imaging. 2023. PMID: 37741928 Free PMC article. Review.
-
Artificial Intelligence in Lung Cancer Screening: The Future Is Now.Cancers (Basel). 2023 Aug 30;15(17):4344. doi: 10.3390/cancers15174344. Cancers (Basel). 2023. PMID: 37686619 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical